Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2011-3-17
pubmed:abstractText
2-Hydroxyisoquinoline-1,3(2H,4H)-dione was recently discovered as a scaffold for the inhibition of HIV-1 integrase and the ribonuclease H function of HIV-1 reverse transcriptase. First, we investigate its interaction with Mg(2+) and Mn(2+) using different spectroscopic techniques and report that 2-hydroxyisoquinoline-1,3(2H,4H)-dione forms a 1:1 complex with Mg(2+) but a 1:2 complex with Mn(2+). The complex formation requires enolization of the ligand. ESR spectroscopy shows a redox reaction between the ligand and Mn(2+) producing superoxide anions. Second, 2-hydroxyisoquinoline-1,3(2H,4H)-dione, its magnesium complex, and its 4-methyl and 2-hydroxy-4-methoxycarbonylisoquinoline-1,3(2H,4H)-diones were tested as inhibitors of HIV-1 integrase, reverse transcriptase ribonuclease H, and DNA polymerase functions. Their antiviral activities were evaluated and 2-hydroxy-4-methoxycarbonyl-isoquinoline-1,3(2H,4H)-dione was found to inhibit the viral replication of HIV-1 in MT-4 cells. Cross-resistance was measured for this compound on three different viral strains. Experimental data suggest that the antiviral activity of 2-hydroxy-4-methoxycarbonylisoquinoline-1,3(2H,4H)-dione is probably due to the RNase H inhibition.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1520-4804
pubmed:author
pubmed:issnType
Electronic
pubmed:day
24
pubmed:volume
54
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1812-24
pubmed:meshHeading
pubmed-meshheading:21366258-Catalytic Domain, pubmed-meshheading:21366258-Cell Line, pubmed-meshheading:21366258-Chelating Agents, pubmed-meshheading:21366258-Coordination Complexes, pubmed-meshheading:21366258-Drug Resistance, Viral, pubmed-meshheading:21366258-Electron Spin Resonance Spectroscopy, pubmed-meshheading:21366258-HIV Integrase Inhibitors, pubmed-meshheading:21366258-HIV-1, pubmed-meshheading:21366258-Humans, pubmed-meshheading:21366258-Isomerism, pubmed-meshheading:21366258-Isoquinolines, pubmed-meshheading:21366258-Magnesium, pubmed-meshheading:21366258-Magnetic Resonance Spectroscopy, pubmed-meshheading:21366258-Ribonuclease H, Human Immunodeficiency Virus, pubmed-meshheading:21366258-Spectrophotometry, Infrared, pubmed-meshheading:21366258-Structure-Activity Relationship, pubmed-meshheading:21366258-Virus Replication
pubmed:year
2011
pubmed:articleTitle
Magnesium chelating 2-hydroxyisoquinoline-1,3(2H,4H)-diones, as inhibitors of HIV-1 integrase and/or the HIV-1 reverse transcriptase ribonuclease H domain: discovery of a novel selective inhibitor of the ribonuclease H function.
pubmed:affiliation
Universite? Lille Nord de France, F-59000 Lille, France.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't